USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION

摘要

A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided.